KORU Medical Systems (NASDAQ:KRMD) Stock Rating Upgraded by B. Riley

KORU Medical Systems (NASDAQ:KRMD) was upgraded by B. Riley to a “strong-buy” rating in a research note issued on Wednesday, Zacks.com reports.

KORU Medical Systems Price Performance

KORU Medical Systems stock opened at $2.49 on Wednesday. KORU Medical Systems has a 12 month low of $1.98 and a 12 month high of $3.12. The stock’s 50 day moving average is $2.40 and its 200-day moving average is $2.26. The company has a current ratio of 4.01, a quick ratio of 3.37 and a debt-to-equity ratio of 0.02. The company has a market capitalization of $113.71 million, a price-to-earnings ratio of -8.87 and a beta of 0.40.

KORU Medical Systems (NASDAQ:KRMD) last posted its earnings results on Wednesday, May 1st. The company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.04) by $0.02. KORU Medical Systems had a negative return on equity of 25.10% and a negative net margin of 45.24%. The company had revenue of $8.20 million for the quarter, compared to the consensus estimate of $7.49 million. During the same quarter in the prior year, the business earned ($0.05) earnings per share. Equities research analysts expect that KORU Medical Systems will post -0.16 EPS for the current year.

Institutional Investors Weigh In On KORU Medical Systems

Large investors have recently added to or reduced their stakes in the stock. Mesirow Financial Investment Management Inc. acquired a new stake in KORU Medical Systems during the first quarter worth approximately $26,000. Aaron Wealth Advisors LLC acquired a new stake in KORU Medical Systems during the second quarter worth approximately $28,000. Virtu Financial LLC acquired a new stake in KORU Medical Systems during the first quarter worth approximately $63,000. Advisor Resource Council acquired a new stake in KORU Medical Systems during the first quarter worth approximately $63,000. Finally, Bard Associates Inc. grew its position in KORU Medical Systems by 22.5% during the fourth quarter. Bard Associates Inc. now owns 26,710 shares of the company’s stock worth $66,000 after buying an additional 4,910 shares in the last quarter. Institutional investors and hedge funds own 58.60% of the company’s stock.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.